nm23 and p53 expression: Correlation with DNA ploidy and other prognostic parameters in breast cancer

Oncology Reports

Volumn 3, Issue 5, 1996, Pages 957-961

  Midulla, Cecilia ^a   De Iorio, Piera ^a   Valli, Clara ^a   Felici, Alessandra ^a   Serpieri, Daniele Eleuteri ^a   Marzetti, Luigi ^a   Nofroni, Italo ^a   Vecchione, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

breast cancer; DNA ploidy; nm23; p53

Indexed keywords

ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PLOIDY; PRIORITY JOURNAL;

EID: 0029787644     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Slamon DJ: Expression of the nm23 gene and breast cancer prognosis. J Natl Cancer Inst 83: 229-231, 1991.
2. Auer G, Caspersson T and Wallgren A: DNA content and survival in mammary carcinoma. Anal Quant Cytol 3: 161-165, 1980.
3. Steeg PS, Bevilacqua G, Pozzati R, Liotta LA and Sobel ME: Altered expression on nm23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 48: 6550-6554, 1988.
4. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK and McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-203, 1995.
5. Bloom HJC and Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-577, 1957.
6. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51: 445-449, 1991.
7. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
8. Hennessy C, Henry JA, May FEB, Westley BR, Angus B and Iennard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991.
9. Hirayama R, Sawai S, Takagi Y, Mishima Y, Kimura N, Shimada N, Esaki Y, Kurashima C, Utsuyama M and Hirokawa K: Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside dophosphate kinase) and good prognosis in human breast cancer. J Natl Cancer Inst 83: 1249-1250, 1991.
10. Simpson JF, O'Malley F, Dupont WD and Page DL: Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Cancer 73: 2352-2358, 1994.
11. Davidoff AM, Kerns BM, Iglehart JD and Marks JR: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51: 2605-2610, 1991.
12. Dowell SP and Hall PA: The clinical relevance of the p53 tumor suppressor gene. Cytopathology 5: 133-145, 1994.
13. Oren M: p53: the ultimate suppressor gene? FASEB J 6: 3169-3176, 1992.
14. Sastre-Garau X, Lacombe ML, Jouve M, Veron M and Magdelenat H: Nucleoside diphosphate kinase/nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int J Cancer 50: 533-538, 1992.
15. Royds J, Stephenson TJ, Rees RC, Shorthouse AJ and Silcocks PB: nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 85: 727-731, 1993.
16. Kobayashi S, Iwase H, Itoh Y, Fukucka H, Yamashita H, Kuzushima T, Iwata H, Masaoka A and Kimura N: Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers. Jpn J Cancer Res 83: 859-865, 1992.
17. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G and Veronesi U: p53 as an independent prognostic marker in lymph-node negative breast cancer patients. J Natl Cancer Inst 85: 965-969, 1993.
18. Midulla C, Giovagnoli MR, Valli C and Vecchione A: Correlation between ploidy status, erb-B2 and p53 immunohistochemical expression in primary breast carcinoma. Anal Quant Cytol 17: 157-162, 1995.
19. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
20. Dowell SP, Lane DP and Hall PA: The immunocytochemical detection of p53 protein in cytological specimens: technical considerations. Cytopathology 5: 76-81, 1994.